Designing effective drug and device development programs for hospitalized heart failure: A proposal for pretrial registries

Recent international phase III clinical trials of novel therapies for hospitalized heart failure (HHF) have failed to improve the unacceptably high postdischarge event rate. These large studies have demonstrated notable geographic and site-specific variation in patient profiles and enrollment. Possi...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Greene, Stephen J., Shah, Ami N., Butler, Javed, Ambrosy, Andrew P., Anker, Stefan D., Chioncel, Ovidiu, Collins, Sean P., Dinh, Wilfried, Dunnmon, Preston M., Fonarow, Gregg C., Lam, Carolyn S. P., Mentz, Robert J., Pieske, Burkert, Roessig, Lothar, Rosano, Giuseppe M. C., Sato, Naoki, Vaduganathan, Muthiah, Gheorghiade, Mihai
Format: Artigo
Langue:Inglês
Publié: 2014
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4160662/
https://ncbi.nlm.nih.gov/pubmed/25066552
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ahj.2014.05.009
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires